InvestSMART

Medibank Private Limited (ASX: MPL) - ETF Exposure

Current share price for MPL : $5.270 0.02 (0.38%)+

Medibank Private Limited (MPL) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a private health insurer, underwriter and distributes private health insurance policies under its two brands, Medibank and ahm. The Group also provides a range of virtual health, home care, preventative health and primary care services through its Amplar Health division, which includes the Myhealth medical clinics.

MPL General Information +

ASX Code MPL
Website http://medibank.com.au
Industry/Sector Life & Health Insurance
Market Cap ($M) 14,513
MPL Share Price $5.270
Day High $5.300
Day Low $5.220
Last Close $5.250
MPL Share Price Movement $0.02 ( 0.38% )
Prices as at 16:40, 20 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to MPL

As one of Australia's largest companies by market capitalisation, MPL is held across 53 ETFs spanning strategies that include life & health insurance exposure . Its weighting in those funds means performance can have an outsized influence - when MPL moves, funds like IMLC, AMVE, MVOL, RDV and AASF that hold it can move with it.

For more concentrated exposure, ETFs such as IMLC (Investors Mutual Concentrated Australian Share Fund (Quoted Managed Fund)) allocate about 4.9% to MPL , while the average exposure across all 53 ETFs that hold it is around 1.2% .

Top ETF holdings

Last updated: ETF data and holdings as at 21 November 2026

Own MPL directly or through an ETF?

How does holding Medibank Private Limited (MPL) shares directly compare to ETFs that include it?

MPL Direct
IMLC
ASX
AMVE
CBOE
MVOL
ASX
RDV
ASX
AASF
ASX
Holdings 1 company 13 holdings 68 holdings 101 holdings 116 holdings 44 holdings
MPL Weight 100% 4.9% 4.8% 2.8% 2.7% 2.6%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.99% p.a. 0.55% p.a. 0.3% p.a. 0.34% p.a. 0.78% p.a.
Approx. Yield 3.9% 8.09% - 3.07% 4.02% 6.85%
Star Ratings - star starstar starstarstar starstarstarstar starstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not MPL's direct yield. Annual cost uses each ETF's MER.

MPL Exposure on $10,000 investment

How a $10,000 investment in Medibank Private Limited (MPL) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Medibank Private Limited (MPL) Direct share $5.270 -2.41% -$241 $9,759
Investors Mutual Concentrated Australian Share Fund (Quoted Managed Fund) (IMLC) Equity - Australia Strategy $4.150 0% $0 $10,000
AB Managed Volatility Equities Fund - MVE Class - Active ETF (AMVE) Equity - Australia Strategy $1.885 2.72% +$272 $10,272
ishares Edge MSCI Australia Minimum Volatility ETF (MVOL) Equity - Australia Strategy $35.680 -3.75% -$375 $9,625
Russell Invest High Div Aust Shares ETF (RDV) Equity - Australia Strategy $34.730 -3.53% -$353 $9,647
Airlie Australian Share Fund (Managed Fund) (AASF) Equity - Australia Strategy $3.720 -5.58% -$558 $9,442

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Medibank Private Limited (MPL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 10.9¢ 100% 2 Sep 2026 8 Oct 2026 - - -
Result 8.3¢ 100% 26 Feb 2026 18 Mar 2026 - - -
HFResult 10.2¢ 100% 10 Sep 2025 9 Oct 2025 - - -

See all dividends from Medibank Private Limited (MPL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Medibank Private Limited (MPL) price-sensitive announcements

MPL - FY26 Results - Investor Presentation
Medibank Private Limited's FY26 results showcase a strong financial performance, with a 30
Medibank Private Limited (MPL)
20 Aug 2026 | 7:50 AM
MPL - FY26 Results - Media Release
Medibank Private Limited reported its FY26 financial results highlighting a 6.7% increase
Medibank Private Limited (MPL)
20 Aug 2026 | 7:49 AM
MPL - FY26 Appendix 4E, Financial Report and Sustainability Report
The document pertains to Medibank Private Limited's financial results for the fiscal year
Medibank Private Limited (MPL)
20 Aug 2026 | 7:45 AM
MPL - HY26 Results - Investor Presentation
Medibank Private Limited's HY26 results showcase a solid financial performance with a grou
Medibank Private Limited (MPL)
19 Feb 2026 | 7:41 AM

Medibank Private Limited (MPL) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
Financials $14,514 Results of 2026 Annual General Meeting 18 Nov 2026 1:45PM $5.285 $5.270 fallen by 0.28%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
Financials $14,514 2026 AGM Chair and CEO address 18 Nov 2026 8:31AM $5.360 $5.270 fallen by 1.68%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
Financials $14,514 Proxy Form 2026 9 Oct 2026 8:19AM $4.570 $5.270 risen by 15.32%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
Financials $14,514 Notice of Annual General Meeting 2026 9 Oct 2026 8:19AM $4.570 $5.270 risen by 15.32%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
Financials $14,514 Becoming a substantial holder 2 Oct 2026 8:17AM $4.510 $5.270 risen by 16.85%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
Financials $14,514 Ceasing to be a substantial holder 1 Oct 2026 8:13AM $4.620 $5.270 risen by 14.07%

MPL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $674.48 $24.49 6.40% 16.17 19.50 4.92% 100.0%
2025F $633.91 $23.02 29.80% 17.20 18.50 4.67% 100.0%
2024A $570.10 $17.74 -4.40% 20.30 16.60 4.61% 100.0%

MPL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Generation Development Group Limited (GDG) $1,138M -0.4398 0.3487 0.2369 34.2649 25.4054 20.5390 0.71% 0.98% 1.46%
Medibank Private Limited (MPL) $14,459M 0.2486 0.0805 0.0386 21.2465 19.6629 18.9326 3.66% 4.10% 4.38%
NIB Holdings Limited (NHF) $3,351M -0.0922 0.1341 0.1267 18.1697 16.0216 14.2203 4.98% 4.40% 4.91%

MPL Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.58 20.70 5.97 3.48
Market 0.27 13.00 1.00 0.72
Sector 0.62 18.40 2.19 1.31

MPL Directors

Name Position Start Date
Mr David Koczkar Chief Executive Officer, Managing Director 17 May 2021
Ms Kathryn Joy Fagg Non-Executive Director 31 Mar 2022
Dr Lisa Margaret McIntyre Non-Executive Director 19 Nov 2025
Ms Jacqueline Cherie Hey Non-Executive Director 19 Nov 2025
Mr Peter Dobie Everingham Non-Executive Director 31 Mar 2022
Mr Gerard Dalbosco Non-Executive Director 21 May 2021
Mr Michael (Mike) John Wilkins Non-Executive Director, Non-Executive Chairman 25 May 2017

Medibank Private Limited (MPL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
24 Aug 2026 HEY, Jacqueline Buy Indirect Shares 14,000 $1.000 $14,000.000
2 Mar 2026 HEY, Jacqueline Buy Indirect Shares 11,448 $4.420 $50,600.160
27 Feb 2026 EVERINGHAM, Peter Buy Indirect Shares 25,000 $4.410 $110,250.000

See all changes in directors' interest & trades for Medibank Private Limited (MPL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MPL Management

Name Position
Mei Ramsay Group General Counsel,Company Secretary
Robert Read Group Lead - Amplar Health
Mark Rogers Group Lead - CFO & Group Strategy
Felicia Trewin Group Lead - Data & Technology
Milosh Milisavljevic Group Lead - Other Executive Office
Kylie Bishop Group Lead - People, Spaces & Sustainability
Meaghan Telford Group Lead - Policy, Advocacy & Reputation

MPL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Medibank Private Limited (MPL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
275,641,770 (10.01%) Australiansuper Pty Ltd
229,260,406 (8.32%) State Street Corporation and subsidiaries
193,895,716 (7.04%) BlackRock Group
193,021,153 (7.01%) The Vanguard Group,Inc
142,685,723 (5.18%) JPmorgan Chase & Co. and its affiliates

MPL Calendar of Events

Date Event
15 September 2027 Report (Annual)
19 August 2027 Report (Prelim)
18 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.